Related Experiment Video

Updated: Aug 11, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.6K

Hepatitis B virus infection combined with nonalcoholic fatty liver disease: Interaction and prognosis

Lili Liu1, Hong Li1, Yang Zhang2

  • 1The Third Unit, Department of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.

Heliyon
|February 7, 2023
PubMed

Keywords:
AVT, antiviral therapyAntiviral efficacyBMI, body mass indexCHB, chronic hepatitis BCI, confidence intervalETV, entecavirHBV infectionHBV, hepatitis B virusHBeAg, hepatitis B e antigenHBsAg, hepatitis B surface antigenHCC, hepatocellular carcinomaHDL, high-density lipoproteinHDL-C, high-density lipoprotein-cholesterolHR, hazard ratioHS, hepatis steatosisHepatocellular carcinomaLDL-C, low-density lipoprotein cholesterolLiver fibrosisNA, nucleos(t)ide analogueNAFLD, nonalcoholic fatty liver diseaseNASH, nonalcoholic steatohepatitisNR, not reportedNonalcoholic fatty liver diseaseOR, odds ratioPEG-IFN, pegylated interferonTAF, tenofovir alafenamideTDF, tenofovirTLR4, Toll-Like Receptor 4aHR, adjusted hazard rationon-HDL-C, non-high-density lipoprotein-cholesterol

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.3K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.3K

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
867
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
163
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
122
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
178